down arrow

cbdMD, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US12482W3097
USD
0.61
0.02 (3.17%)

Dec 04

ASE

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

0.570.64

52 Week

0.476.54
Valuation
Technical
Day's Volume

CASH

463.69 k

Shareholding (Mar 2025)

FII

0.69%

Held by 10 FIIs

DII

97.24%

Held by 2 DIIs

Promoter

0.00%

How big is cbdMD, Inc.?

22-Jun-2025

As of Jun 18, cbdMD, Inc. has a market capitalization of 7.32 million, with net sales of 19.59 million and a net profit of -0.15 million over the last four quarters. As of September 2024, the company reported shareholder's funds of 1.96 million and total assets of 10.58 million.

Market Cap: As of Jun 18, cbdMD, Inc. has a market capitalization of 7.32 million, categorizing it as a Micro Cap company.<BR><BR>Recent Quarterly Performance: For the latest four quarters, cbdMD, Inc. reported net sales of 19.59 million and a net profit of -0.15 million.<BR><BR>Balance Sheet Snapshot: As of September 2024, the company reported shareholder's funds of 1.96 million and total assets of 10.58 million.

Read More

What does cbdMD, Inc. do?

22-Jun-2025

cbdMD, Inc. specializes in consumer hemp-based cannabidiol (CBD) products within the Pharmaceuticals & Biotechnology industry. As of March 2025, it reported net sales of $5 million and has a market cap of $7.32 million.

Overview: <BR>cbdMD, Inc. operates in the Pharmaceuticals & Biotechnology industry, focusing on consumer hemp-based cannabidiol (CBD) products.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 5 Million (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: 0 Million (Quarterly Results - Mar 2025) <BR>Market cap: USD 7.32 Million (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: NA (Loss Making) <BR>Industry P/E: NA <BR>Dividend Yield: 0.00% <BR>Debt Equity: -1.02 <BR>Return on Equity: -119.47% <BR>Price to Book: 7.32<BR><BR>Contact Details: <BR>Address: 8845 Red Oak Blvd, CHARLOTTE NC: 28217-5593 <BR>Tel: 1 704 4453060 <BR>Website: https://www.cbdmd.com/

Read More

Is cbdMD, Inc. overvalued or undervalued?

20-Sep-2025

As of February 9, 2021, cbdMD, Inc. is considered overvalued with a deteriorating outlook, reflected in its high Price to Book Value of 8.51, negative financial metrics including a P/E ratio of -3.7225, and a significant year-to-date stock decline of -76.01% compared to the S&P 500's 12.22% return.

As of 9 February 2021, cbdMD, Inc. moved from fair to risky, indicating a deterioration in its valuation outlook. The company appears to be overvalued, particularly given its negative financial metrics. The Price to Book Value stands at 8.51, while the EV to EBITDA ratio is 7.49, suggesting that the market is pricing the company at a premium despite its loss-making status. Additionally, the ROE is alarmingly low at -119.47%, highlighting significant inefficiencies in generating returns for shareholders.<BR><BR>In comparison to its peers, cbdMD, Inc. has a P/E ratio of -3.7225, which is less favorable than Mannatech, Inc. at -6.5265 and Flora Growth Corp. at -1.0973, both of which also face challenging valuations. The company's stock has significantly underperformed against the S&P 500, with a year-to-date return of -76.01% compared to the index's 12.22%, reinforcing the notion that it is overvalued in the current market environment.

Read More

Is cbdMD, Inc. technically bullish or bearish?

20-Sep-2025

As of September 2, 2025, cbdMD, Inc. is in a mildly bearish trend with mixed indicators, showing a 1-week return of 2.95% and a 1-month return of 5.82%, but down 76.01% year-to-date compared to the S&P 500's 12.22% gain.

As of 2 September 2025, the technical trend for cbdMD, Inc. has changed from bearish to mildly bearish. The current stance is mildly bearish, driven by conflicting indicators: the MACD is mildly bullish on both weekly and monthly time frames, while Bollinger Bands are bearish on the monthly and mildly bearish on the weekly. The daily moving averages indicate a bearish trend. The KST shows a mildly bullish signal on the weekly but bearish on the monthly, and the OBV is mildly bullish on the weekly with no trend on the monthly.<BR><BR>In terms of performance, cbdMD, Inc. has seen a 1-week return of 2.95% compared to the S&P 500's 1.05%, and a 1-month return of 5.82% against the S&P 500's 2.33%. However, year-to-date, the stock is down 76.01%, significantly underperforming the S&P 500, which is up 12.22%.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

USD 6 Million (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.05

stock-summary
Return on Equity

-27.74%

stock-summary
Price to Book

1.03

Revenue and Profits:
Net Sales:
5 Million
(Quarterly Results - Jun 2025)
Net Profit:
-1 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-15.1%
0%
-15.1%
6 Months
-36.67%
0%
-36.67%
1 Year
-83.88%
0%
-83.88%
2 Years
-89.52%
0%
-89.52%
3 Years
88.76%
0%
88.76%
4 Years
-99.88%
0%
-99.88%
5 Years
-99.94%
0%
-99.94%

cbdMD, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News

Is cbdMD, Inc. technically bullish or bearish?

As of 2 September 2025, the technical trend for cbdMD, Inc. has changed from bearish to mildly bearish. The current stance is mildly bearish, driven by conflicting indicators: the MACD is mildly bullish on both weekly and monthly time frames, while Bollinger Bands are bearish on the monthly and mildly bearish on the weekly. The daily moving averages indicate a bearish trend. The KST shows a mildly bullish signal on the weekly but bearish on the monthly, and the OBV is mildly bullish on the weekly with no trend on the monthly. In terms of performance, cbdMD, Inc. has seen a 1-week return of 2.95% compared to the S&P 500's 1.05%, and a 1-month return of 5.82% against the S&P 500's 2.33%. However, year-to-date, the stock is down 76.01%, significantly underperforming the S&P 500, which is up 12.22%....

Read More

Is cbdMD, Inc. overvalued or undervalued?

As of 9 February 2021, cbdMD, Inc. moved from fair to risky, indicating a deterioration in its valuation outlook. The company appears to be overvalued, particularly given its negative financial metrics. The Price to Book Value stands at 8.51, while the EV to EBITDA ratio is 7.49, suggesting that the market is pricing the company at a premium despite its loss-making status. Additionally, the ROE is alarmingly low at -119.47%, highlighting significant inefficiencies in generating returns for shareholders. In comparison to its peers, cbdMD, Inc. has a P/E ratio of -3.7225, which is less favorable than Mannatech, Inc. at -6.5265 and Flora Growth Corp. at -1.0973, both of which also face challenging valuations. The company's stock has significantly underperformed against the S&P 500, with a year-to-date return of -76.01% compared to the index's 12.22%, reinforcing the notion that it is overvalued in the current...

Read More
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
-13.31%
EBIT Growth (5y)
13.76%
EBIT to Interest (avg)
-11.15
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.02
Sales to Capital Employed (avg)
4.35
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
10.25%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
8.51
EV to EBIT
-6.23
EV to EBITDA
7.49
EV to Capital Employed
-7.49
EV to Sales
0.38
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-119.47%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
No Trend
Mildly Bearish
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 4 Schemes (2.07%)

Foreign Institutions

Held by 10 Foreign Institutions (0.69%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is -2.13% vs -7.84% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is -80.00% vs 0.00% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "4.60",
          "val2": "4.70",
          "chgp": "-2.13%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.50",
          "val2": "0.10",
          "chgp": "-600.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-0.90",
          "val2": "-0.50",
          "chgp": "-80.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-196.40%",
          "val2": "-102.30%",
          "chgp": "-9.41%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Sep 2024 is -19.42% vs -31.64% in Sep 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Sep 2024 is 83.84% vs 67.33% in Sep 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "19.50",
          "val2": "24.20",
          "chgp": "-19.42%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-1.40",
          "val2": "-6.30",
          "chgp": "77.78%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.50",
          "val2": "-13.00",
          "chgp": "96.15%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-3.70",
          "val2": "-22.90",
          "chgp": "83.84%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-163.70%",
          "val2": "-383.70%",
          "chgp": "22.00%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQstock-summary
Jun'25
Mar'25
Change(%)
Net Sales
4.60
4.70
-2.13%
Operating Profit (PBDIT) excl Other Income
-0.50
0.10
-600.00%
Interest
0.00
0.00
Exceptional Items
0.00
-0.00
Consolidate Net Profit
-0.90
-0.50
-80.00%
Operating Profit Margin (Excl OI)
-196.40%
-102.30%
-9.41%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Jun 2025 is -2.13% vs -7.84% in Mar 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is -80.00% vs 0.00% in Mar 2025

All Quarterly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
19.50
24.20
-19.42%
Operating Profit (PBDIT) excl Other Income
-1.40
-6.30
77.78%
Interest
0.00
0.00
Exceptional Items
-0.50
-13.00
96.15%
Consolidate Net Profit
-3.70
-22.90
83.84%
Operating Profit Margin (Excl OI)
-163.70%
-383.70%
22.00%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Sep 2024 is -19.42% vs -31.64% in Sep 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Sep 2024 is 83.84% vs 67.33% in Sep 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About cbdMD, Inc. stock-summary
stock-summary
cbdMD, Inc.
Pharmaceuticals & Biotechnology
cbdMD Inc, formerly Level Brands, Inc., owns and operates consumer hemp-based cannabidiol (CBD) brand, cbdMD. The Company’s products categories include CBD gummies, CBD tinctures, CBD topical, CBD bath bombs, CBD Vape oils and CBD pet products.
Company Coordinates stock-summary
Company Details
8845 Red Oak Blvd , CHARLOTTE NC : 28217-5593
stock-summary
Tel: 1 704 4453060
stock-summary
https://www.cbdmd.com/
stock-summary
Registrar Details
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."